AA Pharma Consultancy Limited

Acorah Software Products - Accounts Production 14.5.501 false true 30 June 2022 1 July 2021 false 1 July 2022 30 June 2023 30 June 2023 07677961 Miss Melissa Fleur Jones iso4217:GBP iso4217:EUR iso4217:USD xbrli:shares xbrli:pure xbrli:pure 07677961 2022-06-30 07677961 2023-06-30 07677961 2022-07-01 2023-06-30 07677961 frs-core:CurrentFinancialInstruments 2023-06-30 07677961 frs-core:ShareCapital 2023-06-30 07677961 frs-core:RetainedEarningsAccumulatedLosses 2023-06-30 07677961 frs-bus:PrivateLimitedCompanyLtd 2022-07-01 2023-06-30 07677961 frs-bus:FilletedAccounts 2022-07-01 2023-06-30 07677961 frs-bus:SmallEntities 2022-07-01 2023-06-30 07677961 frs-bus:AuditExempt-NoAccountantsReport 2022-07-01 2023-06-30 07677961 frs-bus:SmallCompaniesRegimeForAccounts 2022-07-01 2023-06-30 07677961 frs-bus:Director1 2022-07-01 2023-06-30 07677961 frs-countries:EnglandWales 2022-07-01 2023-06-30 07677961 2021-06-30 07677961 2022-06-30 07677961 2021-07-01 2022-06-30 07677961 frs-core:CurrentFinancialInstruments 2022-06-30 07677961 frs-core:ShareCapital 2022-06-30 07677961 frs-core:RetainedEarningsAccumulatedLosses 2022-06-30
Registered number: 07677961
AA Pharma Consultancy Limited
Unaudited Financial Statements
For The Year Ended 30 June 2023
Unaudited Financial Statements
Contents
Page
Balance Sheet 1
Notes to the Financial Statements 2
Page 1
Balance Sheet
Registered number: 07677961
2023 2022
Notes £ £ £ £
CURRENT ASSETS
Debtors 4 1,950 1,950
1,950 1,950
Creditors: Amounts Falling Due Within One Year 5 (1,546 ) (1,546 )
NET CURRENT ASSETS (LIABILITIES) 404 404
TOTAL ASSETS LESS CURRENT LIABILITIES 404 404
NET ASSETS 404 404
CAPITAL AND RESERVES
Called up share capital 6 1 1
Profit and Loss Account 403 403
SHAREHOLDERS' FUNDS 404 404
For the year ending 30 June 2023 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
The member has not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The director acknowledges his responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies' regime.
The company has taken advantage of section 444(1) of the Companies Act 2006 and opted not to deliver to the registrar a copy of the company's Profit and Loss Account.
On behalf of the board
Miss Melissa Fleur Jones
Director
25/03/2024
The notes on page 2 form part of these financial statements.
Page 1
Page 2
Notes to the Financial Statements
1. General Information
AA Pharma Consultancy Limited is a private company, limited by shares, incorporated in England & Wales, registered number 07677961 . The registered office is The Old Post Office, Nuffield, Henley On Thames, Oxfordshire, RG9 5SS.
2. Accounting Policies
2.1. Basis of Preparation of Financial Statements
The financial statements have been prepared under the historical cost convention and in accordance with Financial Reporting Standard 102 section 1A Small Entities "The Financial Reporting Standard applicable in the UK and Republic of Ireland" and the Companies Act 2006.
3. Average Number of Employees
Average number of employees, including directors, during the year was: NIL (2022: NIL)
- -
4. Debtors
2023 2022
£ £
Due within one year
Other debtors 1,950 1,950
1,950 1,950
5. Creditors: Amounts Falling Due Within One Year
2023 2022
£ £
Bank loans and overdrafts 10 10
Director's loan account 1,536 1,536
1,546 1,546
6. Share Capital
2023 2022
£ £
Allotted, Called up and fully paid 1 1
Page 2